<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Geographic Access Matrix - Chaos & Order Edition 21</title>
    <style>
        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Arial, sans-serif;
            background: #0a1628;
            color: #e0e6ed;
            padding: 40px 20px;
            margin: 0;
        }
        .container {
            max-width: 900px;
            margin: 0 auto;
        }
        h1 {
            text-align: center;
            font-size: 24px;
            margin-bottom: 10px;
            color: #fff;
        }
        .subtitle {
            text-align: center;
            color: #8a9ba8;
            margin-bottom: 40px;
            font-size: 14px;
        }
        .matrix {
            display: grid;
            gap: 20px;
            margin-bottom: 40px;
        }
        .company-row {
            background: #1a2332;
            border-radius: 8px;
            padding: 20px;
            border-left: 4px solid #4a90e2;
            transition: transform 0.2s, box-shadow 0.2s;
        }
        .company-row:hover {
            transform: translateX(5px);
            box-shadow: 0 4px 12px rgba(74, 144, 226, 0.3);
        }
        .company-row.constrained {
            border-left-color: #f5a623;
        }
        .company-header {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-bottom: 15px;
        }
        .company-name {
            font-size: 18px;
            font-weight: 600;
            color: #fff;
        }
        .company-domicile {
            color: #8a9ba8;
            font-size: 14px;
        }
        .access-badge {
            padding: 4px 12px;
            border-radius: 4px;
            font-size: 12px;
            font-weight: 600;
            text-transform: uppercase;
        }
        .access-badge.all {
            background: #27ae60;
            color: #fff;
        }
        .access-badge.constrained {
            background: #f5a623;
            color: #fff;
        }
        .access-details {
            display: grid;
            grid-template-columns: repeat(3, 1fr);
            gap: 15px;
            margin-top: 15px;
        }
        .access-item {
            text-align: center;
            padding: 12px;
            background: #0f1823;
            border-radius: 6px;
        }
        .access-item-label {
            font-size: 11px;
            text-transform: uppercase;
            color: #8a9ba8;
            margin-bottom: 8px;
            letter-spacing: 0.5px;
        }
        .access-status {
            font-size: 14px;
            font-weight: 500;
        }
        .status-full {
            color: #27ae60;
        }
        .status-uncertain {
            color: #f5a623;
        }
        .legend {
            background: #1a2332;
            border-radius: 8px;
            padding: 20px;
            margin-top: 30px;
        }
        .legend-title {
            font-size: 14px;
            font-weight: 600;
            margin-bottom: 12px;
            color: #fff;
        }
        .legend-item {
            display: flex;
            align-items: center;
            margin-bottom: 8px;
            font-size: 13px;
        }
        .legend-color {
            width: 20px;
            height: 20px;
            border-radius: 4px;
            margin-right: 10px;
        }
        .footer {
            text-align: center;
            margin-top: 40px;
            font-size: 12px;
            color: #8a9ba8;
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>Geographic Access to Global Innovation</h1>
        <p class="subtitle">Which pharmaceutical companies can source innovation from all three power centers?</p>
        
        <div class="matrix">
            <!-- European Pharma - Unrestricted -->
            <div class="company-row">
                <div class="company-header">
                    <div>
                        <div class="company-name">AstraZeneca</div>
                        <div class="company-domicile">United Kingdom • LSE: AZN</div>
                    </div>
                    <div class="access-badge all">Unrestricted</div>
                </div>
                <div class="access-details">
                    <div class="access-item">
                        <div class="access-item-label">US Biotech</div>
                        <div class="access-status status-full">✓ Full Access</div>
                    </div>
                    <div class="access-item">
                        <div class="access-item-label">Chinese Innovation</div>
                        <div class="access-status status-full">✓ Full Access</div>
                    </div>
                    <div class="access-item">
                        <div class="access-item-label">European R&D</div>
                        <div class="access-status status-full">✓ Full Access</div>
                    </div>
                </div>
            </div>

            <div class="company-row">
                <div class="company-header">
                    <div>
                        <div class="company-name">Roche</div>
                        <div class="company-domicile">Switzerland • SIX: ROG</div>
                    </div>
                    <div class="access-badge all">Unrestricted</div>
                </div>
                <div class="access-details">
                    <div class="access-item">
                        <div class="access-item-label">US Biotech</div>
                        <div class="access-status status-full">✓ Full Access</div>
                    </div>
                    <div class="access-item">
                        <div class="access-item-label">Chinese Innovation</div>
                        <div class="access-status status-full">✓ Full Access</div>
                    </div>
                    <div class="access-item">
                        <div class="access-item-label">European R&D</div>
                        <div class="access-status status-full">✓ Full Access</div>
                    </div>
                </div>
            </div>

            <div class="company-row">
                <div class="company-header">
                    <div>
                        <div class="company-name">Novartis</div>
                        <div class="company-domicile">Switzerland • NYSE: NVS</div>
                    </div>
                    <div class="access-badge all">Unrestricted</div>
                </div>
                <div class="access-details">
                    <div class="access-item">
                        <div class="access-item-label">US Biotech</div>
                        <div class="access-status status-full">✓ Full Access</div>
                    </div>
                    <div class="access-item">
                        <div class="access-item-label">Chinese Innovation</div>
                        <div class="access-status status-full">✓ Full Access</div>
                    </div>
                    <div class="access-item">
                        <div class="access-item-label">European R&D</div>
                        <div class="access-status status-full">✓ Full Access</div>
                    </div>
                </div>
            </div>

            <!-- US Pharma - Potentially Constrained -->
            <div class="company-row constrained">
                <div class="company-header">
                    <div>
                        <div class="company-name">Eli Lilly</div>
                        <div class="company-domicile">United States • NYSE: LLY</div>
                    </div>
                    <div class="access-badge constrained">Potentially Constrained</div>
                </div>
                <div class="access-details">
                    <div class="access-item">
                        <div class="access-item-label">US Biotech</div>
                        <div class="access-status status-full">✓ Full Access</div>
                    </div>
                    <div class="access-item">
                        <div class="access-item-label">Chinese Innovation</div>
                        <div class="access-status status-uncertain">⚠ BIOSECURE Uncertain</div>
                    </div>
                    <div class="access-item">
                        <div class="access-item-label">European R&D</div>
                        <div class="access-status status-full">✓ Acquisitions Only</div>
                    </div>
                </div>
            </div>

            <div class="company-row constrained">
                <div class="company-header">
                    <div>
                        <div class="company-name">Pfizer</div>
                        <div class="company-domicile">United States • NYSE: PFE</div>
                    </div>
                    <div class="access-badge constrained">Potentially Constrained</div>
                </div>
                <div class="access-details">
                    <div class="access-item">
                        <div class="access-item-label">US Biotech</div>
                        <div class="access-status status-full">✓ Full Access</div>
                    </div>
                    <div class="access-item">
                        <div class="access-item-label">Chinese Innovation</div>
                        <div class="access-status status-uncertain">⚠ BIOSECURE Uncertain</div>
                    </div>
                    <div class="access-item">
                        <div class="access-item-label">European R&D</div>
                        <div class="access-status status-full">✓ Acquisitions Only</div>
                    </div>
                </div>
            </div>
        </div>

        <div class="legend">
            <div class="legend-title">Understanding BIOSECURE Impact</div>
            <div class="legend-item">
                <div class="legend-color" style="background: #27ae60;"></div>
                <div><strong>Unrestricted:</strong> Can partner with Chinese CROs, license innovations, acquire biotechs globally without regulatory constraints</div>
            </div>
            <div class="legend-item">
                <div class="legend-color" style="background: #f5a623;"></div>
                <div><strong>Potentially Constrained:</strong> Senate BIOSECURE targets BGI/MGI (DoD 1260H list). House reconciliation could expand to WuXi entities affecting 79% of US biopharma</div>
            </div>
        </div>

        <div class="footer">
            Chaos & Order Edition 21 | Data as of October 2025 | Source: BIOSECURE Act (S.3635), BIO Survey (May 2024)
        </div>
    </div>
</body>
</html>
